致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human CLEC2D, Avi-hFc-tag
目录号 NBL-241036
别名 CLEC2D; C-type lectin domain family 2 member D;Lectin-like NK cell receptor;Lectin-like transcript 1;LLT-1;CLAX;LLT1;OCIL;CLEC2D
外观 see COA
分子量 Arg60-Val191
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q9UHP7-1
备注2
目录号 规格 价格 库存状态  
NBL-241036-100ug 100ug Inquire Inquire
NBL-241036-1mg 1mg Inquire Inquire
NBL-241036-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human CLEC2D, Avi-hFc-tag


Catalog#:

NBL-241036


Description:

NebuSelect™ Recombinant Human CLEC2D, Avi-hFc-tag(Cat#NBL-241036) is expressed in HEK293 with hFc tag and Avi tag at the N-Terminus.It contains Arg60-Val191.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 59.1 kDa. Due to glycosylation, the protein migrates to 72-78 kDa based on Bis-Tris PAGE result.


Target Name:

CLEC2D; C-type lectin domain family 2 member D;Lectin-like NK cell receptor;Lectin-like transcript 1;LLT-1;CLAX;LLT1;OCIL;CLEC2D


Target Information:

C-type lectin domain family 2, member D (CLEC2D) is implicated in the immune response. Pre-eclampsia and HIV infection have opposing immune responses. The contrasting expression of CLEC2D in HIV infection and pre-eclampsia is demonstrative of the immunosuppressive and pro-inflammatory roles of the respective pathologies. However, this implication may be confounded by highly active anti-retroviral treatment (HAART).


Amino Acid Sequence: 

Arg60-Val191


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品